Dr. Tushar Ranchod, MD

Dr. Ranchod practices at Walnut Creek Endoscopy Center in Walnut Creek, California.

Dr. Ranchod's NPI, 1316003304, was assigned on December 28, 2006. Dr. Ranchod graduated from UCSF School of Medicine in 2004. Dr. Ranchod holds California license A113274.

Dr. Ranchod's primary practice is Walnut Creek Endoscopy Center, at 365 Lennon Lane, Suite 100, Walnut Creek, CA 94598. The practice phone is (925) 939-4600.

Dr. Ranchod's primary practice is Walnut Creek Endoscopy Center in Walnut Creek, California. Dr. Ranchod is also affiliated with Alta Bates Summit Medical Center | Alta Bates Campus. The medical group on file is Alameda Health System. Dmand AI also links Dr. Ranchod to 1 more dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ranchod practices, 4 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Ranchod's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Ranchod is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Ranchod's licenses on file in 3 states: California, Michigan and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Ranchod treats.

CMS data shows 58,227 Medicare services from Dr. Ranchod across 17 procedure codes in 2024, for 962 Medicare patients. Medicare paid $2,538,111 for them. Every service was in an office.

CMS counts 962 Medicare patients who saw Dr. Ranchod in 2024. The largest group is 75 to 84, with 353 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ranchod's median patient age at 71, with 53% women.

In 2024, Dr. Ranchod wrote 212 Medicare Part D claims for 84 patients. 50% of them were for generic drugs. CMS names the drug for 156 of them, across 4 drugs with 11 or more claims each, at $7,064 in total drug cost. In 2023, CMS named 145 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ranchod for performance year 2024, reported as part of a group. Dr. Ranchod accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 25 papers to Dr. Ranchod, published from 2009 to 2011. The most frequent topics are Visual Acuity, Retinal Diseases and Fluorescein Angiography. Dr. Ranchod has published most often in Retina. Dr. Ranchod's most frequent co-authors are Antonio Capone, MD, Tarek Shawky Hassan, MD and Vincent Trien-Vinh Ho, MD.

CMS Open Payments shows 72 general payments to Dr. Ranchod from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $925.

Dmand AI lists 1 award for Dr. Ranchod, most recently Ronald G. Michels Foundation Fellowship in 2009.

Dr. Ranchod graduated from UCSF School of Medicine in 2004. Dr. Ranchod is a member of AAO.

Dr. Ranchod is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.